MCM2 and neuroblastoma: Remarkably, the number of MCM2-positive cells was reduced with a similar pattern among treatments than observed for Ki67 (Figure 2D), indicating that the combination of the three drugs is the most effective combination to counteract the proliferation of NB cells in the nodules, with a better outcome than cisplatin and Cis/Fen.